STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentrationJing Chen, Mubiao Liu, Huihua Cai et al.|Clinical & Translational Oncology|2022Cited by 10
Identification of anoikis-related tumor microenvironment characteristics and prognostic signature in ovarian cancer at bulk and single-cell levelsZhenye Tang, Shanyang He, Chenfei Zhou et al.|Research Square|2024Cited by 0
BRD4-Associated Chromatin Remodeling Signature Links Epigenetic Regulation to Immune Landscape in Ovarian CancerShanyang He, Hongxi Chen, Jing Chen et al.|Research Square|2025Cited by 0
Identification of anoikis-related tumor microenvironment characteristics and prognostic signature in ovarian cancer at bulk and single-cell levelsZhenye Tang, Shanyang He, Ping Jin et al.|Discover Oncology|2025Cited by 0